Next Article in Journal
Tris(3,7-dihydroxyflavonolate-κO3,O4)chromium(III) Complex
Previous Article in Journal
Article Menu

Export Article

Open AccessShort Note
Molbank 2016, 2016(1), M885;


R.G.C.C. (Research Genetic Cancer Centre) Ltd., Industrial Area of Florina, GR 53100 Florina, Greece
Author to whom correspondence should be addressed.
Academic Editor: Norbert Haider
Received: 18 December 2015 / Revised: 7 January 2016 / Accepted: 11 January 2016 / Published: 19 January 2016
Full-Text   |   PDF [364 KB, uploaded 19 January 2016]   |  


A novel hybrid consisting of quinazoline and adenine moieties has been synthesized as a precursor of a potential biologically active target compound. The structure of 9-(4-methoxyquinazolin-2-yl)-9H-purin-6-amine (2) was characterized and confirmed using the following spectroscopic methods: LC-UV-MS, 1H-NMR, 13C-NMR and HSQC-NMR. View Full-Text
Keywords: 9-substituted adenine; quinazoline 9-substituted adenine; quinazoline

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary materials


Share & Cite This Article

MDPI and ACS Style

Vlachou, I.; Kourtidou, E.; Papasotiriou, I. 9-(4-Methoxyquinazolin-2-yl)-9H-purin-6-amine. Molbank 2016, 2016, M885.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molbank EISSN 1422-8599 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top